SIGNIFICANCE OF THE HYDROXYL GROUPS OF STEROIDS IN PROMOTING GROWTH by Huggins, Charles & Jensen, Elwood V.
SIGNIFICANCE  OF  THE  HYDROXYL  GROUPS  OF  STEROIDS  IN 
PROMOTING  GROWTH* 
B~ CHARLES HUGGINS, M.D., Am) ELWOOD V. JENSEN,  PH.D. 
(From the Ben May Laboratory for Cancer Research of the University of 
Chicago, Chicago) 
Plal~: 30 
(Received for publication, May 3, 1954) 
In the hypophysectomized rat which is guarded from contact with steroids 
in  the ration and  environment, the uterus  and  vagina are atrophic but  they 
remain highly responsive to the difunctional steroids (1) which promote their 
growth and hence compose an assay system. Utilizing it we have found that 
functional groups at positions 3  and  17 in the steroids mentioned participate 
in  the induction of growth, but that these physiologically active centers are 
equivalent neither in quantitative effects nor in the type of growth which they 
evoke. The state  of oxidation at  both  sites and  the  degree of saturation  of 
the A  and B  rings have much to do with determining the quantity and  the 
pattern of the growth response. 
In  order to evaluate  the importance of the individual structural  elements 
of steroid hormones in accelerating cell growth, an investigation was made of 
steroids possessing an oxygen function at either position 3  or position 17 but 
not at both sites. The results to be set forth in this present paper demonstrate 
that in  such monofunctional steroids of the androstane series the possession 
of a/~-hydroxyl at a  specific site, position 17,  is essential for the stimulation 
of growth.  In  the phenolic estrane  series,  however, a  compound,  17-desoxy- 
estradiol,  with  a  single hydroxyl group  at  position  3  is  active in  promoting 
growth, a confirmation of earlier work (2). 
A series of monofunctional steroids  was investigated by Kochakian (3)  with re- 
spect to their effects on the growth of the kidney, the seminal vesicle, and the pros- 
tate of castrate mice. The compounds  tested were androstan-3a-ol; androstan-3B-ol; 
5-androsten-3/3-ol;  androstan-17/3-ol;  17-methylandrostan-17/3-ol;  androstan-17-one; 
and  4-androsten-3-one.  Kochakian  (3)  found  that  none of these  steroids,  admin- 
istered by implantation as pellets,  had biological activity, but the absorption of the 
compounds  from the subcutaneous  tissues  was  low. To overcome the difficulty  of 
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poor solubility, Kochakian (4) subsequently studied the effects  of the oral adminis- 
tration of 17-methylandrostan-17~-ol (0.1  to 0.2 mg. per gin. of food) for a  30 day 
period and observed that this compound was highly active in promoting growth of 
the kidney and, to a lesser  extent, the prostate and seminal vesicles. 
Prelog,  Ruzicka,  and  Wieland  (2)  reported  that  17-desoxyestradiol was  moder- 
ately active in causing estrus in ovariectomized rats. It has been stated that 3-des- 
oxyequilenin (5) has weak estrogenic properties, but this effect was not observed by 
Bachman and Wilds (6). 
Methods 
BiologicaL--The methods employed were those described in an accompanying paper (1). 
The hypophysectomized rats were injected with compounds, in sesame oil, at a dose of 1 mg. 
daily for 7 days beginning at age 38 days; necropsy was performed at age 45 days. The uterine 
weight ratio is the average of the weight of the uterus of 4 injected rats divided by a similar 
value of the uterus of 4 rats receiving the solvent alone. Most of the compounds were ad- 
ministered at 2 levels of dosage, 1 nag. and 3 nag. per diem. 
When the ventral prostate was visible in the gross, its lobes were excised at necropsy and 
promptly weighed on a torsion balance. 
Ch~nical.--Some of the steroids  1 employed in this study were obtained through the gener- 
osity of other investigators  as  follows: androstaa-3-one,  2-androsten-3-one and androstan- 
3#-ol, from Dr. T. F. Gallagher, Sloan-Kettering Institute for Cancer Research; androstan- 
17#-ol, Dr.  F.  A.  Travers,  Ciba  Pharmaceutical  Products,  Inc.;  androstan-17-one,  Dr. 
Abraham White, Chemical Specialties Co., Inc. 
Certain  steroids were synthesized in this laboratory  by  methods to be described (7) in 
detail  elsewhere:  androstan-3~-ol,  androstan-3~-ol,  4-androsten-3#-ol,  5-androsten-3#-ol, 
androstan-17#-ol,  4-androsten-17#-ol,  5-androsten-17#-ol,  3,5-cycloandrostan-17#-ol,  etio- 
cholan-17~-ol, 4-androsten-3-one,  and  17-desoxyestradiol. 
RESULTS 
Weight  of  the  Vagina,  Prostate,  and  Uteru~.--An  increase  of  the  ratio  of 
uterine  weight  above  unity was  always  accompanied  by an  increase  in  the 
weight of the vagina as well.  Increased weights of the uterus  and vagina oc- 
curred after the administration  of the following compounds in the androstane 
series  (Table  I):  Androstan-17~-ol  (I);  4-androsten-17fl-ol  (II);  and  5-an- 
drosten-17fi-ol (III). All other C19-steroids in this series were inactive in so far 
as they failed to cause an increase of weight of these tissues. 
Two  of  the  compounds,  androstan-17~-ol  (I)  and  4-androsten-17fi-ol  (II) 
caused  growth  of the  prostatic  glands  (range  of weight  7.2  to  10.4  rag.)  to 
such  extent  that  these  vestigial  structures  became  visible  in  the  gross;  the 
epithelium was cylindrical when examined with a microscope (Fig. 6). 
An  increased  weight  of  the  vagina  and  uterus  occurred  after  the  admin- 
istration  of 17-desoxyestradiol  (XIV), but  the  quantities  (Table  II) required 
to produce  growth  were  larger  than  the  quantity  that  was  needed  with  es- 
tradiol-17fl (XV). 
, The chemical formulae of the steroids  used  in  this  paper  are  provided  in Text-fig. 1. c.  nuoGn~s AND E.  v.  JENSEN  243 
TABLE I 
The Uterine Weigkt Ratio and the Weigkt of the Vagina Following the Administration of 
19-Carbon Steroids 
No.  Compound  Uterine weight  Average weight  ratio*  of vagins 
mg. 
I  Androstan-17B-ol  3.0  55.7 
II  4-Androsten-17~-ol  1.4  26.2 
III  5-Androsten-  17B-ol  1.4  25.1 
IV  3,5-Cycla~drostan- 17~-01  1.0  17.8 
V  Etiocholan-17fl-ol  0.9  22.0 
VI  Androstan-17-one  1.0  19.3 
VII  2-Androsten-17-one  1.0  22.0 
VIII  Androstan-3a-ol  1.0  19.8 
IX  Androstan-3~-ol  1.0  22.4 
X  4-Androsten-30-ol  1.0  21.8 
XI  5-Androsten-3~-ol  i. 0  19.2 
XII  4-Androsten-3-one  1.0  18.9 
XIII  Androstan-3-one  I. 0  20.9 
Sesame oil (control)  1.0  21.6 
* Average wel ht of uteri of  4  rats injected with the  compound divided  by the value 
obtained from a similar group injected with the solvent alone. 
TABLE II 
The Weight of the  Uterus and  Vagina Following the  Administration of 17-Desoxyestradiol 
and Estradiol-17B 
No.  Compound  Daily  Weight of  Weight of  amount  uterus*  vagina* 
XIV 
XV 
17-Desoxyestradiol 
17-Desoxyestradiol 
Estradiol-17O 
Estradiol-17B 
Sesame oil 
/~g. 
1 
2.5 
0.005 
0.01 
rag. 
21.9 
50.7 
24.5 
61.4 
19.3 
rag. 
23.9 
31.2 
24.4 
34.0 
21.6 
* Each value the average of 4 rats. 
Action  of  Monofunctional  Steroids  on  the  Vaginal  Epithelium.--Keratin- 
ization or stratification of  the  vaginal epithelium did not follow the  admin- 
istration  of  any monofunctional steroid  in  the  C19-series.  In  this  series  all 
the  compounds which promoted growth  of  the  vaginal epithelium produced 
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mucous  cells.  Growth  of  this  sort  occurred  after  the  administration  of 
androstan-17tS-ol  (Fig.  1);  4-androsten-1715-ol  (Fig.  2);  5-androsten-17/5-ol 
(Fig.  3). No other compound listed in Table I  induced growth in the vaginal 
epithelium. 
The  administration  of  17-desoxyestradiol  at  a  daily level  of  1 /~g. caused 
growth both  of the basal  cells and  the mucous cells.  An increase  in  dosage 
I 
O  O 
I  HOt" 
I 
OH 
I 
TExT-FIo. 1 
of this compound to 2.5 #g. per diem induced keratinization of the epithelium 
(Fig. 5). 
DISCUSSION 
The site of the functional group proved to be critical  for the induction of 
growth by monofunctional steroids of the androstane series.  Growth occurred 
only when the active group was present at position 17; steroids with an iden- 
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Further the state of oxidation of the chemical group at position 17 was crit- 
ical in determining activity, in the growth process, of monofunctional steroids 
of the androstane series.  Whereas the presence of a r-oriented hydroxyl group 
at  position  17  conferred  considerable  activity in  promoting  growth,  com- 
pounds with a ketone group at CI~ or Ca were devoid of this capacity (Fig. 4). 
In addition to possessing the 17r-hydroxyl group the steroid nucleus must 
have certain geometric requirements in order to accelerate growth processes. 
Highest activity was observed in  the  saturated  androstane compound with 
the 5a-configuration (I). In contrast to observations with difunctional steroids 
(1) the presence of a A4 or A  5 double bond (II, HI) lowered the activity some- 
what whereas 17~-hydroxysteroids with the 5r-configuration (V) or the/-ster- 
oid structure (IV) are completely inactive. 
The influence of the 17r-hydroxyl group on physiologic processes was fur- 
ther illustrated by the growth of the ventral prostate which followed the ad- 
ministration  of  androstan-17fl-ol  (I),  or  4-androsten-17fl-ol  (II).  Testoster- 
one is known to have the property of inducing growth of the prostatic glands 
of female rats (8,9). 
In sum, the capacity of the monofunctional steroids in the C10-series to in- 
duce growth of the female genital tract would seem to require (a) the presence 
of a hydroxyl group at (b) a critical site, position 17, in a molecule which has 
(c) closely restricted geometric specifications. 
In contrast to  the C~9-steroids the promotion of growth by phenolic ster- 
oids of the estrane series  does not require  the presence of the  17~-hydroxyl 
group although its presence increased their activity. In confirmation of pre- 
vious findings (2)  17-desoxyestradiol markedly stimulated uterine growth and 
induced  keratinization  in  the  vagina,  although  larger  quantities  were  re- 
quired than with estradiol-17~. 
CONCLUSIONS 
The presence of a  17r-hydroxyl group endows the simple androstane mole- 
cule with the ability to produce growth of the uterus, vagina, and prostate of 
the female hypophysectomized albino rat. It appears that hydrogen atoms at 
position 17  are of critical importance since related compounds with a  ketone 
group at this site are inactive. Monofunctional steroids with a  hydroxyl or a 
ketone group at position 3 likewise are devoid of activity. 
If a phenolic A-ring is present in monofunctional steroids the 17r-hydroxyl 
group  is  not obligatory for growth.  Proliferation of the  uterus  and  vagina 
were found to follow the administration of 17-desoxyestradiol. 
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EXPLANATION OF  PLATE 30 
The  photomicrographs  are  of  paraffin  sections  stained  with  hematoxylin  and 
eosin. The compounds had been injected into hypophysectomized rats from age 38 
to 44 days and necropsy was performed at age 45  days. The tissue,  the compound 
injected  with the daily dosage, and  the magnification are stated. 
FIG. 1. Vaginal epithelium of a  rat injected with androstan-17~-ol,  1 rag.  Prolif- 
eration of the superficial and deep layers of the mucosa is shown.  X  500. 
FIG. 2.  Vaginal  mucosa of a  rat injected  with 4-androsten-17jS-ol,  1 mg.  While 
growth of the epithelium has occurred it is less than in rats injected with  androstan- 
17~-ol;  see Fig. 1.  ×  500. 
FIG. 3. Vaginal mucosa of a  rat injected with 5-androsten-17~-ol, 3 rag.  Growth 
of the  epithelium  induced  by this  compound  is less than  that  which  followed  ad- 
ministration of androstan-17~-ol; see Fig.  I.  ×  500. 
FIG. 4. Vaginal mucosa of a  rat injected with androstan-17-one,  3 rag. This com- 
pound did not promote growth of the vaginal epithelium.  X  500. 
FIG. 5.  Extensive growth  of the  deep layer of the  vaginal mucosa with  keratin 
formation on the surface occurring in a  rat injected with  17-desoxyestradioI, 2.5 #g. 
X 500. 
FIG. 6. Proliferation of the female prostate of the rat induced by the administra- 
tion of 4-androsten-17~-ol,  1 rag.  X  275. THE JOURNAL OF EXPERIMENTAL  HEDICINE  VOL.  i00  ~LA~E  30 
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